Cwm, LLC Pds Biotechnology Corp Transaction History

Cwm, LLC

$21.2 Billion
Q2 2024

A detailed history of Cwm, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Cwm, LLC holds 42 shares of PDSB stock, worth $160. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 61 31.15%

Holding current value

$160

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 09, 2024	SELL	$2.55 - $4.02 $48 - $76	-19 Reduced 31.15%	42 $0
Q4 2023 Feb 01, 2024	BUY	$3.95 - $6.58 $240 - $401	61 New	61 $0

Others Institutions Holding PDSB

# of Institutions

Shares Held

5.47M

Call Options Held

155K

Put Options Held

61.7K

Vanguard Group Inc Valley Forge, PA

1.41M
Shares

$5.38 Million
0.0% of portfolio
Black Rock Inc. New York, NY

487K
Shares

$1.86 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

381K
Shares

$1.46 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

378K
Shares

$1.44 Million
0.0% of portfolio
Inspirion Wealth Advisors, LLC

360K
Shares

$1.37 Million
0.16% of portfolio

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $109M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account